Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Cooper

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
Journal of Blood Medicine|May 2, 2018
Educational needs of hematologists and laboratory professionals regarding factor activity assaysDorothy M Adcock, Mazi Rasulnia, Natalia Holot, et al.
Analytical Chemistry|May 18, 2017
Sensitive Analysis of Protein Adsorption to Colloidal Gold by Differential Centrifugal SedimentationAdam M Davidson, Mathias Brust, David L Cooper, et al.
Journal of Blood Medicine|August 4, 2017
Identification of people with acquired hemophilia in a large electronic health record databaseMichael Wang, Anissa Cyhaniuk, David L Cooper, et al.
Journal of Blood Medicine|October 2, 2019
Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC)Madhvi Rajpurkar, Stacy E Croteau, Lisa Boggio, et al.
Cognitive Neurodynamics|June 2, 2011
Synchronized changes to relative neuron populations in postnatal human neocortical developmentDavid L Cooper, James E Gentle, Ernest Barreto, et al.
Chemical Communications (Cambridge, England)|February 24, 2006
The electronic structure of nitrilimine: absence of the carbenic formFausto Cargnoni, Giorgio Molteni, David L Cooper, et al.
Pediatric Blood & Cancer|January 22, 2013
Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: the experience of the Hemostasis and Thrombosis Research Society (HTRS) Registry (2004-2008)Ellis J Neufeld, Kapil Saxena, Craig M Kessler, et al.
Journal of Blood Medicine|January 29, 2014
A novel supplemental approach to capturing post-marketing safety information on recombinant factor VIIa in acquired hemophilia: the Acquired Hemophilia Surveillance projectSteven R Lentz, Anand Tandra, Robert Z Gut, et al.
The Journal of Physical Chemistry. A|June 14, 2012
Spin-coupled theory for 'N electrons in M orbitals' active spacesPeter B Karadakov, David L Cooper, Brian J Duke, et al.
Journal of Blood Medicine|August 16, 2019
Efficacy of EHL N9-GP for on-demand treatment of bleeding episodes in hemophilia B: analysis of pivotal trial dataMiguel A Escobar, Christopher E Walsh, David L Cooper, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
Journal of Blood Medicine|May 2, 2018
Educational needs of hematologists and laboratory professionals regarding factor activity assaysDorothy M Adcock, Mazi Rasulnia, Natalia Holot, et al.
Analytical Chemistry|May 18, 2017
Sensitive Analysis of Protein Adsorption to Colloidal Gold by Differential Centrifugal SedimentationAdam M Davidson, Mathias Brust, David L Cooper, et al.
Journal of Blood Medicine|August 4, 2017
Identification of people with acquired hemophilia in a large electronic health record databaseMichael Wang, Anissa Cyhaniuk, David L Cooper, et al.
Journal of Blood Medicine|October 2, 2019
Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC)Madhvi Rajpurkar, Stacy E Croteau, Lisa Boggio, et al.
Cognitive Neurodynamics|June 2, 2011
Synchronized changes to relative neuron populations in postnatal human neocortical developmentDavid L Cooper, James E Gentle, Ernest Barreto, et al.
Chemical Communications (Cambridge, England)|February 24, 2006
The electronic structure of nitrilimine: absence of the carbenic formFausto Cargnoni, Giorgio Molteni, David L Cooper, et al.
Pediatric Blood & Cancer|January 22, 2013
Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: the experience of the Hemostasis and Thrombosis Research Society (HTRS) Registry (2004-2008)Ellis J Neufeld, Kapil Saxena, Craig M Kessler, et al.
Journal of Blood Medicine|January 29, 2014
A novel supplemental approach to capturing post-marketing safety information on recombinant factor VIIa in acquired hemophilia: the Acquired Hemophilia Surveillance projectSteven R Lentz, Anand Tandra, Robert Z Gut, et al.
The Journal of Physical Chemistry. A|June 14, 2012
Spin-coupled theory for 'N electrons in M orbitals' active spacesPeter B Karadakov, David L Cooper, Brian J Duke, et al.
Journal of Blood Medicine|August 16, 2019
Efficacy of EHL N9-GP for on-demand treatment of bleeding episodes in hemophilia B: analysis of pivotal trial dataMiguel A Escobar, Christopher E Walsh, David L Cooper, et al.
Pageof 11